This Article Full Text Full Text (PDF) Submit a related Letter to the Editor View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eustatia-Rutten, C. F. A. Articles by Smit, J. W. Search for Related Content PubMed PubMed Citation Articles by Eustatia-Rutten, C. F. A. Articles by Smit, J. W. Related Collections Thyroid Endocrine Oncology

Survival and Death Causes in Differentiated Thyroid Carcinoma

Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

Address all correspondence and requests for reprints to: Jan W. A. Smit, M.D., Ph.D., Department of Endocrinology, C4-R, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: jwasmit{at}lumc.nl.

Background: Survival studies in differentiated thyroid carcinoma (DTC) may be biased because they have been performed in heterogeneous populations. In addition, specific death causes in DTC have not been documented well in the literature.

Aims: The aim of our study was to investigate survival and specific death causes in a homogeneous cohort of DTC patients.

Patients: Patients included 366 consecutive patients with DTC who had all been treated according to the same protocol for initial therapy and follow-up.

Methods: Prognostic factors for DTC-related death were analyzed by univariate Cox regression analysis, followed by stepwise multivariate Cox regression analysis. Standardized mortality rates (SMR) were calculated using normal mortality rates for the entire Dutch population.

Results: During follow-up of 8.3 ± 4.6 yr, 82 patients (22.4%) died. At multivariate Cox-regression analysis, tumor stage T4, distant metastases, and advanced age were associated with an increased relative risk for DTC-related death. SMR for the entire group was 2.32. This could be explained by increased SMR in patients with stage T4, distant metastases, or advanced age. Death causes could be verified in 80 patients: 52 died of DTC, 28 due to other causes. Ten of the 20 patients with stage T1–3M0 died from thyroid carcinoma.

Conclusion: Relative risk for thyroid cancer-related death and SMR are significantly increased in patients with stage T4 and M1 or advanced age. Although death risk is not increased in T1–3 M0 patients, DTC contributed significantly to mortality in all patient categories.

This article has been cited by other articles:

				F. A Verburg, U. Mader, M. Luster, and C. Reiners Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases Eur. J. Endocrinol., April 1, 2009; 160(4): 619 - 624. [Abstract] [Full Text] [PDF]

				E. Roti, E. C degli Uberti, M. Bondanelli, and L. E Braverman Thyroid papillary microcarcinoma: a descriptive and meta-analysis study Eur. J. Endocrinol., December 1, 2008; 159(6): 659 - 673. [Abstract] [Full Text] [PDF]

				R. T. Kloos Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1519 - 1525. [Abstract] [Full Text] [PDF]

				G. Brabant Thyrotropin Suppressive Therapy in Thyroid Carcinoma: What Are the Targets? J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1167 - 1169. [Full Text] [PDF]

				S.-H. Ahn, Y. Henderson, Y. Kang, C. Chattopadhyay, P. Holton, M. Wang, K. Briggs, and G. L. Clayman An Orthotopic Model of Papillary Thyroid Carcinoma in Athymic Nude Mice Arch Otolaryngol Head Neck Surg, February 1, 2008; 134(2): 190 - 197. [Abstract] [Full Text] [PDF]

				B. H.-H. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging Ann. Surg. Oncol., February 1, 2007; 14(2): 730 - 738. [Abstract] [Full Text] [PDF]

				T. Y. Farrag, F. R. Lin, C. W. Cummings, J. J. Sciubba, W. M. Koch, P. W. Flint, and R. P. Tufano Importance of routine evaluation of the thyroid gland prior to open partial laryngectomy. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1047 - 1051. [Abstract] [Full Text] [PDF]

eLetters: